| Literature DB >> 26893918 |
Shin-Hang Moon1, Jae-Cheol Moon1, Da-Hee Heo1, Young-Hyup Lim1, Joon-Hyouk Choi1, Song-Yi Kim1, Ki-Seok Kim1, Seung-Jae Joo1.
Abstract
BACKGROUND: Arterial stiffness of patients with coronary artery disease (CAD), which is expected to be increased due to a generalized atherosclerotic process of human body, may be more evident after the acute increase of blood pressure (BP) or peripheral vascular resistance. Isometric handgrip exercise is a simple and easily applicable method to achieve this goal. We investigated the changes of hemodynamic parameters and arterial stiffness indexes after handgrip exercise in patients with CAD.Entities:
Keywords: Aortic pressure; Arterial stiffness; Coronary artery disease; Isometric exercise; Pulse wave velocity
Year: 2015 PMID: 26893918 PMCID: PMC4750784 DOI: 10.1186/s40885-015-0016-7
Source DB: PubMed Journal: Clin Hypertens ISSN: 2056-5909
Figure 1Study protocol. Baseline arterial pressure waveforms were traced at the aortic root (WAo) and external iliac artery (WIA). A submaximal target at 30% ~ 40% of maximal handgrip power was used for isometric handgrip exercise. Arterial waveforms were recorded at 1, 2, and 3 min in the aortic root and at 3 min in the external iliac artery after exercise.
Figure 2Measurements of augmentation pressure (AP), augmentation index (AIx), and pulse wave velocity (PWV). AP and AIx were measured at the central aortic waveforms. AP was maximal systolic blood pressure (SBP) minus forward pressure (FP). AIx was defined as AP divided by pulse pressure (PP) expressed as a percentage. PWV was calculated using the ECG-gated time difference of the upstroke of the arterial waveforms between the aortic root (TAo) and the external iliac artery (TIA) and the distance between them measured using a catheter.
Baseline characteristics of patients
|
|
|
| |
|---|---|---|---|
| Age | 63.4 ± 8.8 | 62.0 ± 10.8 | 0.656 |
| Male | 20 (66.7%) | 8 (66.7%) | 1.000 |
| Height (cm) | 161.8 ± 9.5 | 161.7 ± 8.2 | 0.958 |
| Weight (kg) | 65.8 ± 11.2 | 68.4 ± 14.0 | 0.523 |
| Body mass index (kg/m2) | 25.01 ± 2.90 | 25.99 ± 4.06 | 0.387 |
| Smoker | 10 (33.3%) | 1 (8.3%) | 0.247 |
| Hypertension | 23 (76.7%) | 7 (58.3%) | 0.274 |
| Diabetes mellitus | 9 (30.0%) | 2 (16.7%) | 0.464 |
| Hyperlipidemia | 28 (93.3%) | 8 (66.7%) | 0.046 |
| Chronic kidney disease | 3 (10.0%) | 1 (8.3%) | 1.000 |
| Laboratory findings | |||
| Hemoglobin (g/dL) | 14.07 ± 1.78 | 13.58 ± 2.00 | 0.445 |
| Fasting blood glucose (mg/dL) | 109.9 ± 27.7 | 99.0 ± 14.80 | 0.206 |
| HbA1c (%) | 6.41 ± 0.82 | 5.97 ± 0.31 | 0.016 |
| Creatinine (mg/dL) | 1.22 ± 0.22 | 1.21 ± 0.32 | 0.924 |
| Total cholesterol (mg/dL) | 152.4 ± 29.7 | 175.4 ± 21.9 | 0.020 |
| Triglyceride (mg/dL) | 115.3 ± 52.5 | 128.5 ± 107.7 | 0.595 |
| HDL cholesterol (mg/dL) | 46.5 ± 10.7 | 50.4 ± 10.4 | 0.288 |
| LDL cholesterol (mg/dL) | 88.4 ± 24.2 | 102.4 ± 20.3 | 0.084 |
| hsCRP (mg/dL) | 0.240 ± 0.405 | 0.101 ± 0.101 | 0.270 |
| LVH by ECG criteria | 5 (16.7%) | 2 (16.7%) | 1.000 |
| Medications | |||
| Aspirin | 21 (95.5%) | 13 (68.4%) | 0.036 |
| Clopidogrel | 17 (77.3%) | 7 (36.8%) | 0.012 |
| Calcium channel blockers | 12 (54.5%) | 6 (31.6%) | 0.209 |
| ACEI | 5 (22.7%) | 4 (21.1%) | 1.000 |
| Angiotensin receptor blockers | 6 (27.3%) | 6 (31.6%) | 1.000 |
| Beta-blockers | 13 (59.1%) | 11 (57.9%) | 1.000 |
| Diuretics | 4 (18.2%) | 3 (15.8%) | 1.000 |
| Alpha-blockers | 2 (9.1%) | 3 (15.8%) | 0.649 |
| Nitrate | 7 (31.8) | 4 (21.1%) | 0.499 |
| Statins | 20 (90.9%) | 14 (73.7%) | 0.219 |
ACEI angiotension-converting enzyme inhibitor, CAD coronary artery disease, LVH left ventricular hypertrophy.
Baseline central and peripheral hemodynamic parameters and handgrip power
|
|
|
| |
|---|---|---|---|
| Central hemodynamics | |||
| Central HR (/min) | 64.6 ± 9.1 | 65.1 ± 10.8 | 0.724 |
| Central SBP (mmHg) | 114.7 ± 18.1 | 124.6 ± 23.6 | 0.201 |
| Central DBP (mmHg) | 61.0 ± 7.7 | 68.1 ± 13.0 | 0.053 |
| Central PP (mmHg) | 53.7 ± 16.8 | 56.5 ± 19.1 | 0.702 |
| FP (mmHg) | 105.3 ± 17.3 | 114.6 ± 22.8 | 0.173 |
| AP (mmHg) | 9.3 ± 5.8 | 10.0 ± 8.1 | 0.765 |
| AIx (%) | 17.7 ± 9.7 | 16.5 ± 12.2 | 0.757 |
| Peripheral hemodynamics | |||
| Peripheral HR (/min) | 65.1 ± 9.7 | 67.7 ± 12.5 | 0.451 |
| Peripheral SBP (mmHg) | 121.9 ± 18.8 | 131.8 ± 22.5 | 0.156 |
| Peripheral DBP (mmHg) | 60.2 ± 8.3 | 66.2 ± 12.5 | 0.079 |
| Peripheral PP (mmHg) | 61.7 ± 17.8 | 65.6 ± 19.2 | 0.536 |
| PWV (m/s) | 10.03 ± 1.99 | 9.82 ± 1.10 | 0.675 |
| Isometric handgrip exercise | |||
| Handgrip power, maximal (kg) | 34.5 ± 12.7 | 36.6 ± 16.5 | 0.661 |
| Handgrip power at exercise (kg) | 12.7 ± 2.7 | 12.8 ± 2.8 | 0.944 |
| Handgrip power % | 38.7 ± 5.6 | 38.2 ± 9.1 | 0.821 |
AIx augmentation index, AP augmentation pressure, CAD coronary artery disease, DBP diastolic blood pressure, FP forward pressure, HR heart rate, PP pulse pressure, PWV pulse wave velocity, SBP systolic blood pressure.
Changes of hemodynamic parameters after isometric handgrip exercise
|
|
|
|
| |
|---|---|---|---|---|
| Patients with CAD ( | ||||
| Central HR (/min) | 64.6 ± 9.1 | 67.6 ± 9.9* | 68.6 ± 9.8* | 70.7 ± 13.3* |
| Central SBP (mmHg) | 114.7 ± 18.1 | 132.0 ± 19.8* | 136.1 ± 20.5* | 137.0 ± 21.3* |
| Central DBP (mmHg) | 61.0 ± 7.7 | 68.4 ± 8.4* | 69.5 ± 8.4* | 70.1 ± 9.1* |
| Central PP (mmHg) | 53.7 ± 16.8 | 63.5 ± 17.6* | 66.6 ± 19.0* | 66.3 ± 20.4* |
| FP (mmHg) | 105.3 ± 17.3 | 118.4 ± 18.1* | 121.9 ± 19.0* | 123.5 ± 19.8* |
| AP (mmHg) | 9.3 ± 5.8 | 13.8 ± 7.0* | 14.3 ± 7.7* | 14.7 ± 8.3* |
| AIx (%) | 17.7 ± 9.7 | 22.1 ± 9.9* | 22.0 ± 10.5* | 22.3 ± 10.7* |
| Peripheral SBP (mmHg) | 121.9 ± 18.8 | 141.5 ± 24.6* | ||
| Peripheral DBP (mmHg) | 60.2 ± 8.3 | 64.0 ± 9.3* | ||
| Peripheral PP (mmHg) | 61.7 ± 17.8 | 77.5 ± 4.0* | ||
| PWV (m/s) | 10.03 ± 1.99 | 11.09 ± 2.45* | ||
| Patients without CAD ( | ||||
| Central HR (/min) | 65.1 ± 10.8 | 69.0 ± 11.3* | 70.9 ± 11.4* | 72.0 ± 12.6* |
| Central SBP (mmHg) | 124.6 ± 23.6 | 138.7 ± 25.0* | 141.9 ± 27.2* | 142.6 ± 27.1* |
| Central DBP (mmHg) | 68.1 ± 13.0 | 75.0 ± 13.7* | 76.3 ± 15.4* | 76.8 ± 14.5* |
| Central PP (mmHg) | 56.5 ± 19.1 | 63.7 ± 19.9* | 65.7 ± 19.9* | 65.8 ± 18.8* |
| FP (mmHg) | 114.6 ± 22.8 | 125.8 ± 26.1* | 128.2 ± 27.9* | 129.6 ± 28.6* |
| AP (mmHg) | 10.0 ± 8.1 | 12.9 ± 10.8* | 13.8 ± 10.3* | 13.0 ± 9.3 |
| AIx (%) | 16.5 ± 12.2 | 19.3 ± 14.3 | 20.4 ± 13.6* | 19.9 ± 13.5 |
| Peripheral SBP (mmHg) | 131.8 ± 22.5 | 141.2 ± 29.1* | ||
| Peripheral DBP (mmHg) | 66.2 ± 12.5 | 67.3 ± 13.1 | ||
| Peripheral PP (mmHg) | 65.6 ± 19.2 | 73.9 ± 22.2* | ||
| PWV (m/s) | 9.82 ± 1.10 | 10.12 ± 1.79 | ||
*p < 0.05 vs. baseline.
AIx augmentation index, AP augmentation pressure, CAD coronary artery disease, DBP diastolic blood pressure, FP forward pressure, HR heart rate, PP pulse pressure, PWV pulse wave velocity, SBP systolic blood pressure.
Figure 3Changes of (A) augmentation index (AIx) and (B) pulse wave velocity (PWV) after isometric handgrip exercise in patients with or without coronary artery disease (CAD). AIx and PWV increased at 3 min after exercise only in patients with CAD. Values are mean ± SD.